On February 5th to 8th, 2024, the 23rd Medlab Middle East, a globally renowned medical industry event, was held at the Dubai World Trade Center in the United Arab Emirates. The exhibition attracted nearly a thousand manufacturers from over 40 countries worldwide and with over 30,000 attendees to participate. As a leading global professional exhibition for laboratory and diagnostic industry, Medlab covers all products and services of medical laboratories. A platform has been built for product display, professional communication, and business cooperation for global manufacturers of laboratory equipment, diagnostic reagents, medical consumables, and medical service facilitators, providing premium business opportunities for the global healthcare market.
At this exhibition, Shanghai Sunbio showcased products such as UG series, UP series and UR series coagulation analyzers, UL-2000LAS coagulation assembly line, thrombosis and haemostasis diagnostic reagents, medical consumables, etc. The products include semi-automatic and fully automatic coagulation analyzers, thrombosis and haemostasis diagnostic reagents and medical consumables applicable for various brands of coagulation analyzers, covering the demand for thrombosis and haemostasis testing items in different markets of various countries around the world. The products aroused great interests from global attendees with the stable characteristics, excellent quality, and perfect compatibility. The upcoming new products such as Protein C, Protein S, Factors, Anti-Xa, and Lupus Anticoagulant have also attracted the attentions and expectations of worldwide cooperative facilitators.
As a manufacturer who has been deeply involved in the field of clinical diagnosis for over two decades, Shanghai Sunbio equipped with the complete integrated product lines of thrombosis and hemostasis diagnostic systems. In the future, we will continue to make breakthroughs in the research and development innovation of instruments and reagents, bringing new speeds and standards for coagulation diagnosis, and serving healthcare institutions globally.